Related references
Note: Only part of the references are listed.Novel bivalent BET inhibitor N2817 exhibits potent anticancer activity and inhibits TAF1
Qian Wu et al.
BIOCHEMICAL PHARMACOLOGY (2021)
The Promise and Peril of Chemical Probe Negative Controls
Jinyoung Lee et al.
ACS CHEMICAL BIOLOGY (2021)
Application of Atypical Acetyl-lysine Methyl Mimetics in the Development of Selective Inhibitors of the Bromodomain-Containing Protein 7 (BRD7)/Bromodomain-Containing Protein 9 (BRD9) Bromodomains
Michael A. Clegg et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins
Robert J. Watson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Bromodomains: a new target class for drug development
Andrea G. Cochran et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Dual Inhibition of TAF1 and BET Bromodomains from the BI-2536 Kinase Inhibitor Scaffold
David Remillard et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Chemical Epigenetics: The Impact of Chemical and Chemical Biology Techniques on Bromodomain Target Validation
Matthias Schiedel et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Advancements in the Development of non-BET Bromodomain Chemical Probes
Michael A. Clegg et al.
CHEMMEDCHEM (2019)
Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1
Junghyun L. Suh et al.
BIOCHEMISTRY (2018)
Disrupting Acetyl-lysine Interactions: Recent Advance in the Development of BET Inhibitors
Fa Zhang et al.
CURRENT DRUG TARGETS (2018)
GNE-371, a Potent and Selective Chemical Probe for the Second Bromodomains of Human Transcription-Initiation-Factor TFIID Subunit 1 and Transcription-Initiation-Factor TFIID Subunit 1-like
Shumei Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Structure of human TFIID and mechanism of TBP loading onto promoter DNA
Avinash B. Patel et al.
SCIENCE (2018)
Frameshift Mutations in the Mononucleotide Repeats of TAF1 and TAF1L Genes in Gastric and Colorectal Cancers with Regional Heterogeneity
Hye Rim Oh et al.
PATHOLOGY & ONCOLOGY RESEARCH (2017)
Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains
Lea Bouche et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology
Julian Blagg et al.
CANCER CELL (2017)
The Bromodomain: A New Target in Emerging Epigenetic Medicine
Steven G. Smith et al.
ACS CHEMICAL BIOLOGY (2016)
A Chemical Probe for the ATAD2 Bromodomain
Paul Bamborough et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains
Terry D. Crawford et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talk
Sara Sdelci et al.
NATURE CHEMICAL BIOLOGY (2016)
NanoBRET-A Novel BRET Platform for the Analysis of Protein-Protein Interactions
Thomas Machleidt et al.
ACS CHEMICAL BIOLOGY (2015)
TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations
Jason A. O'Rawe et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2015)
Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors
Paul Bamborough et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
Emmanuel H. Demont et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A Subset of Human Bromodomains Recognizes Butyryllysine and Crotonyllysine Histone Peptide Modifications
E. Megan Flynn et al.
STRUCTURE (2015)
Biased Multicomponent Reactions to Develop Novel Bromodomain Inhibitors
Michael R. McKeown et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Targeting bromodomains: epigenetic readers of lysine acetylation
Panagis Filippakopoulos et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Target validation using chemical probes
Mark E. Bunnage et al.
NATURE CHEMICAL BIOLOGY (2013)
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Panagis Filippakopoulos et al.
CELL (2012)
Bromodomains as therapeutic targets
Susanne Muller et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)
Discovery and Characterizatlion of Small Molecule Inhibitors of the BET Family Bromodomains
Chun-wa Chung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
TAF1 Differentially Enhances Androgen Receptor Transcriptional Activity via Its N-Terminal Kinase and Ubiquitin-Activating and -Conjugating Domains
Peyman Tavassoli et al.
MOLECULAR ENDOCRINOLOGY (2010)
Predicting properties and tuning physicochemical in lead optimization:: Amine basicities
Martin Morgenthaler et al.
CHEMMEDCHEM (2007)
The C-F bond as a tool in the conformational control of amides
CRS Briggs et al.
JOURNAL OF FLUORINE CHEMISTRY (2003)
Share Paper
